Since the Investor Protection Improvement Act (AnSVG) came into force on October 30, 2004, people who hold management positions with a stock issuer and people who are closely related to such a person are required by the terms of § 15a WpHG to report to both the issuer and the Federal Financial Supervisory Authority (BAFin) within five working days any business they have transacted in the issuer’s stock or in related financial instruments, especially derivatives, insofar as the sum total of any such business amounts to EUR 5,000 by the end of the calendar year. As the issuer, aap Implantate AG is required to publish any such notification without delay.

Transactions are listed as follows:


So far, in 2012 no Directors Dealings have been made.